Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand and an EGF receptor ligand composition in subjects with preexisting diabetes
A Standard patent application filed on 14 March 2008 credited to Brand, Stephen J.
Details
Application number :
2008201347
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand and an EGF receptor ligand composition in subjects with preexisting diabetes
Inventor :
Brand, Stephen J.
Agent name :
Davies Collison Cave
Address for service :
Level 10 301 Coronation Drive Milton QLD 4064 Australia
Filing date :
14 March 2008
Associated companies :
Applicant name :
Waratah Pharmaceuticals, Inc.
Applicant address :
1000 Roessler Road Suite N Woburn 01801 United States of America